The serpin SQN-5 is a dual mechanistic-class inhibitor of serine and cysteine proteinases

被引:51
作者
Al-Khunaizi, M
Luke, CJ
Askew, YS
Pak, SC
Askew, DJ
Cataltepe, S
Miller, D
Mills, DR
Tsu, C
Brömme, D
Irving, JA
Whisstock, JC
Silverman, GA
机构
[1] Harvard Univ, Sch Med, Dept Pediat, Childrens Hosp, Boston, MA 02115 USA
[2] Mt Sinai Sch Med, Dept Human Genet, New York, NY 10029 USA
[3] Monash Univ, Dept Biochem & Mol Biol, Melbourne, Vic 3800, Australia
关键词
D O I
10.1021/bi015999x
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
SQN-5 is a mouse serpin that is highly similar to the human serpins SCCA1 (SERPINB3) and SCCA2 (SERPINB4). Previous studies characterizing the biochemical activity of SQN-5 showed that this serpin, like SCCA2, inhibited the chymotrypsin-like enzymes mast cell chymase and cathepsin G. Using an expanded panel of papain-like cysteine proteinases, we now show that SQN-5, like SCCA1, inhibited cathepsins K, L, S, and V but not cathepsin B or H. These interactions were characterized by stoichiometries of inhibition that were nearly 1:1 and second-order rate constants of > 10(4) M-(1) s(-1). Reactive site loop (RSL) cleavage analysis showed that SQN-5 employed different reactive centers to neutralize the serine and cysteine proteinases. To our knowledge, this is the first serpin that serves as a dual inhibitor of both chymotrypsin-like serine and the papain-like cysteine proteinases by employing an RSL-dependent inhibitory mechanism. The ability of serpins to inhibit both serine and/or papain-like cysteine proteinases may not be a recent event in mammalian evolution. Phylogenetic studies suggested that the SCCA and SQN genes evolved from a common ancestor approximately 250-280 million years ago. When the fact that mammals and birds diverged approximately 3 10 million years ago is considered, an ancestral SCCA/ SQN-like serpin with dual inhibitory activity may be present in many mammalian genomes.
引用
收藏
页码:3189 / 3199
页数:11
相关论文
共 47 条
  • [1] Caspase-1 (interleukin-1β-converting enzyme) is inhibited by the human serpin analogue proteinase inhibitor 9
    Annand, RR
    Dahlen, JR
    Sprecher, CA
    de Dreu, P
    Foster, DC
    Mankovich, JA
    Talanian, RV
    Kisiel, W
    Giegel, DA
    [J]. BIOCHEMICAL JOURNAL, 1999, 342 : 655 - 665
  • [2] AULAK KS, 1993, J BIOL CHEM, V268, P18088
  • [3] CHYMOTRYPSIN INHIBITORY ACTIVITY OF NORMAL C1-INHIBITOR AND A P1 ARG TO HIS MUTANT - EVIDENCE FOR THE PRESENCE OF OVERLAPPING REACTIVE CENTERS
    AULAK, KS
    DAVIS, AE
    DONALDSON, VH
    HARRISON, RA
    [J]. PROTEIN SCIENCE, 1993, 2 (05) : 727 - 732
  • [4] A murine ortholog of the human serpin SCCA2 maps to chromosome 1 and inhibits chymotrypsin-like serine proteinases
    Bartuski, AJ
    Kamachi, Y
    Schick, C
    Massa, H
    Trask, BJ
    Silverman, GA
    [J]. GENOMICS, 1998, 54 (02) : 297 - 306
  • [5] BEATTY K, 1980, J BIOL CHEM, V255, P3931
  • [6] Selective regulation of apoptosis: the cytotoxic lymphocyte serpin proteinase inhibitor 9 protects against granzyme B-mediated apoptosis without perturbing the Fas cell death pathway
    Bird, CH
    Sutton, VR
    Sun, JR
    Hirst, CE
    Novak, A
    Kumar, S
    Trapani, JA
    Bird, PI
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 1998, 18 (11) : 6387 - 6398
  • [7] MULTIPLE MURINE ALPHA-1-PROTEASE INHIBITOR GENES SHOW UNUSUAL EVOLUTIONARY DIVERGENCE
    BORRIELLO, F
    KRAUTER, KS
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (21) : 9417 - 9421
  • [8] BROMME D, 1993, J BIOL CHEM, V268, P4832
  • [9] BROMME D, 1994, J BIOL CHEM, V269, P30238
  • [10] Human cathepsin V functional expression, tissue distribution, electrostatic surface potential, enzymatic characterization, and chromosomal localization
    Brömme, D
    Li, ZQ
    Barnes, M
    Mehler, E
    [J]. BIOCHEMISTRY, 1999, 38 (08) : 2377 - 2385